Amlodipine Besylate
- Product NDC
- 76413-141
- 11-digit product format
- 764130141
- Labeler code
- 76413
- Product ID
- 76413-141_e05bd712-ddf8-4d2e-b437-44957f684c50
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Amlodipine Besylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Central Texas Community Health Centers
- Application
- ANDA078226
- Marketing category
- ANDA
- Marketing start
- 2007-09-21
- Marketing end
- 0000-00-00
- Substance
- AMLODIPINE BESYLATE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 76413-141 | I | Inactivated by FDA | 2026-07-31 | ||
| excluded package | package | 76413-141 | 76413-141-30 | I | Inactivated by FDA | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078226-001 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2007-07-09 | |
| A078226-002 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | AB | 2007-07-09 | |
| A078226-003 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | AB | 2007-07-09 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078226-001 | AB |
| A078226-002 | AB |
| A078226-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078226-001 | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2007-07-09 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078226-002 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | AB | 2007-07-09 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078226-003 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | AB | 2007-07-09 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078226-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078226-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078226-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amlodipine Besylate | AMLODIPINE BESYLATE | Safecor Health LLC | 572bc798-c3d9-4fe2-98be-8e1913bda8f3 | 2026-06-12 | Warnings, Adverse reactions | 078226 ANDA078226 |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Cardinal Health 107, LLC | a74239bf-4684-424c-ba4e-6087e363265b | 2026-04-09 | Warnings, Adverse reactions | 078226 ANDA078226 |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Major Pharmaceuticals | edf9b22c-e37e-4b4e-8a64-20bb036c7d2d | 2025-09-05 | Warnings, Adverse reactions | 078226 ANDA078226 |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Zydus Lifesciences Limited | cacb3551-c579-41cb-bed6-4b4d8b0644fc | 2024-11-25 | 078226 ANDA078226 | |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Zydus Pharmaceuticals USA Inc. | fda0739d-b355-478c-acae-8f773a3ec4b3 | 2024-10-18 | Warnings, Adverse reactions | 078226 ANDA078226 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fa898d56-9495-d6f0-309b-68a5d8e3914a | Product name | 4 | 20260305 |
| c19ec24d-2c40-4b8d-7c20-500ffa3660a1 | Product name | 3 | 20260303 |
| b15e9aa6-d523-ca97-480e-570e0543a342 | Product name | 4 | 20251024 |
| 265792b3-b999-c010-7364-a7db20b9d4d9 | Product name | 5 | 20250515 |
| 14c2c15b-f823-4ada-a40e-a440544294dc | Product name | 1 | 20221207 |
| a72887ef-d675-499f-af4b-78688f6855cd | Product name | 1 | 20191002 |
| a4484670-2869-6416-f6ff-03b1b3cbd1b0 | Product name | 2 | 20190415 |
| 4a27501f-a987-48a5-99b4-e983d4744d76 | Product name | 7 | 20181211 |
| 18600d07-613d-bf9c-2711-fe40c06f3393 | Product name | 5 | 20180703 |
| bded1554-44de-900a-5297-403365d6d4b2 | Product name | 3 | 20170110 |
| 1f1c6e4b-bbad-4649-afd1-7a1d671db4b1 | Product name | 1 | 20150316 |
| 63ab5fbf-2a6b-c41d-051a-39e845d718b1 | Product name | 1 | 20140508 |
| 7613b1a5-acb6-4e5e-6048-c44deeeb1212 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 76413-141-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4432-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use amlodipine besylate tablets safely and effectively. See full prescribing information for amlodipine besylate tablets. AMLODIPINE besylate tablets USP, for oral administration Initial U.S. Approval: 1987 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76413-141-30 | Amlodipine Besylate | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197361 | amLODIPine besylate 5 MG Oral Tablet | PSN | 04809c4e-ae49-4c0b-92e2-123156bd8eab | 1 |
| 197361 | amlodipine 5 MG Oral Tablet | SCD | 04809c4e-ae49-4c0b-92e2-123156bd8eab | 1 |
| 197361 | amlodipine (as amlodipine besylate) 5 MG Oral Tablet | SY | 04809c4e-ae49-4c0b-92e2-123156bd8eab | 1 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 76413-141-30 | 76413014130 | 30 in 1 BOTTLE, PLASTIC | Historical |